No Data
HK Stock Market Update | Joinnew Pharmaceutical (06127) Surges Over 5% Against Trend; Institutions Bullish on Mid-to-Long-Term Growth Prospects
Zhaoyan New Drug (06127) has risen more than 5% against the market trend. As of press time, it was up 5.02% at HK$30.98, with a turnover of HK$204 million. Zhitong Finance APP learned that Zhaoyan
Hong Kong Stock Market Midday Review | The Hang Seng Index fell 0.53% in morning trading, while the Hang Seng Biotech Index dropped 2.73%.
ArriVent's global Phase III trial of elisavetinib ended in failure, sending its U.S. stock price plummeting and triggering a broad pullback across the Hong Kong-listed pharmaceutical sector. Zhitong
Hong Kong Stocks in Motion | Pharmaceutical Sector Plunges Across the Board; GenScript Biotech (01548) Drops Over 15%; Joinn Laboratories (06127) Falls More Than 12%
Overnight, the U.S. pharmaceutical sector plunged, weighing on Hong Kong's pharmaceutical stocks, which had posted strong gains the previous day. As of press time, GenScript Biotech (01548) was down 1
Zhitong Statistics on Significant Changes in Hong Kong Stock Connect Holdings | October 7
Zhitong Stock Connect Proportion Volatility Statistics | October 6, 2026 Zhitong Finance APP learned that, according to data disclosed on October 6, 2026, the largest increases in Stock Connect
Zhitong AH Statistics | October 6
AH Statistics | October 6The Zhitong Finance APP learned that, as of the close on October 6, Northeast Electric (00042), Zhejiang Shibaо (01057), and Hongye Futures (03678) ranked first, second, and
Optogenetics Wins 2026 Nobel Prize: Which Pharmaceutical Companies Have Strategic Layouts? What Is Their Progress?
Gelonghui, October 6 — According to The Paper, the Nobel Prize in Physiology or Medicine has brought optogenetics into the spotlight. On October 5, local time, Sweden's Karolinska Institute